Elevance Health Inc
ELV: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|m^ | LOCK|rF># | LOCK|$%$!@Ff |
Elevance Earnings: Mismatched Rates and Utilization Claim Another Victim, Cutting Into 2025 Outlook
Despite 14% operating revenue growth in the second quarter, Elevance's adjusted EPS declined 14% due to mismatched rates and utilization in its individual and Medicaid businesses. Management cut its 2025 EPS outlook by roughly 14% to about $30, and shares initially fell about 10% in July 17 trading.
